LYNDE ROUCHE: Open Payments
NPI 1467588087 · CONCORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 12 payments from 6 companies in 2025. Trend: 2023 $460 · 2024 $622 · 2025 $351
Food & beverage: $351
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 3 | $158 |
| Fresenius USA Marketing, Inc. | 3 | $73 |
| Amgen Inc. | 3 | $57 |
| Aurinia Pharma U.S., Inc. | 1 | $28 |
| Calliditas Therapeutics US Inc. | 1 | $21 |
| Mallinckrodt Hospital Products Inc. | 1 | $14 |
Products named: XPHOZAH 30 MG, VELPHORO, KRYSTEXXA, IBSRELA, LUPKYNIS, TARPEYO, ACTHAR.
Industry payments across CA — which companies pay providers there.
